Skip to main content
See every side of every news story
Get Started
SubscribeLogin
Published • loading... • Updated

Harmony Biosciences Reaffirms Outlook After Record WAKIX Sales

Summary by MyChesCo
PLYMOUTH MEETING, PA — Harmony Biosciences Holdings Inc. (Nasdaq: HRMY) reported preliminary second-quarter WAKIX net product revenue of approximately $261 million, a record for the company, reaffirming its full-year revenue …
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

1 Articles

MyChesCoMyChesCo

Harmony Biosciences Reaffirms Outlook After Record WAKIX Sales

PLYMOUTH MEETING, PA — Harmony Biosciences Holdings Inc. (Nasdaq: HRMY) reported preliminary second-quarter WAKIX net product revenue of approximately $261 million, a record for the company, reaffirming its full-year revenue …

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

MyChesCo broke the news on Sunday, July 26, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)
Blindspot Title And Logo
Stories disproportionately reported by the Left or the Right

Similar News Topics

Plymouth Meeting icon

Plymouth Meeting

News
Feed Dots Icon
For You
Search Icon
SearchBlindspot LogoBlindspotLocal